Emergency

 

Quick Links

 

In The News

 

Health Education

 

Contact Us

Health Services
400 South Orange Avenue
South Orange, N.J. 07079
-------------------------
Phone (973)761-9175
Suggestions or Grievances?
health@shu.edu

Meningitis Immunizations

The New Jersey Law (P.L.2003, c.284, s.2) went into effect in September, 2004.  When you visit your health care provider to meet the University’s entrance medical requirements, you can have the vaccine administered at that time.  Incoming students may also call SHU Health Services to schedule an appointment to receive the immunization. All incoming residential students will be monitored by Health Services for compliance.  You will not be able to register for the spring semester if you are non-compliant.  Students under the age of 25 who are not planning to live in residence may also wish to consider receiving the meningitis immunization to reduce their risk.       

Meningitis and College Students

Meningococcal disease is a rare but potentially life-threatening bacterial infection.  The disease most commonly is defined as either meningococcal meningitis, an inflammation of the membranes surrounding the brain and spinal cord, or meningococcemia, a serious infection of the blood.  It is estimated that 100 to 125 cases of meningococcal disease occur annually on college campuses, and 5 to 15 students die as a result.  The disease can result in permanent brain damage, hearing loss, learning disability, limb amputation, kidney failure or death.  The incidence of this disease has increased since the early 1990’s.  Data suggests that certain social behaviors, such as exposure to passive and active smoking and excessive alcohol consumption, may increase college students’ risk for contracting the disease.  Recent data show that freshmen who live in campus residence halls are 3-6 times more likely to contract the disease.

For more information:

American College Health Association: www.acha.org/projects_programs/meningitis/index.cfm
Centers for Disease Control: www.cdc.gov/mmwr/preview/mmwrhtml/rr4907a2.htm 

Immunization

The  new Menactra Polysaccaharide Conjugate vaccine is felt to provide protection for up to 5-7 years against four of the 5 strains of meningococcal disease, which together account for about 70% of meningococcal cases on college campuses.  The Menactra Conjugate vaccine is recommended by the Advisory Committee on Immunization Practices [ACIP].   Adverse reactions to the vaccination are mild and infrequent, consisting primarily of redness, tenderness, and swelling at the site of the injection lasting up to two days. 

Students are welcome to contact Health Services at 973-761-9175 to schedule an appointment to receive the vaccination. 

Sincerely,

Joan Osthues, RN, C
Director Health Services